Phase I clinical trial of the (131)I-labeled anticarcinoembryonic antigen CIGB-M3 multivalent antibody fragment.
González GP, García IG, González JG, Sánchez LP, Mirabal MV, Marín CC, Ruiz FL, Iglesias EG, de Queralta RL, Toirac RR, Avila MA, Díaz AL, Saura PA, Gavilondo JV, González JP.
González GP, et al.
Cancer Biother Radiopharm. 2011 Jun;26(3):353-63. doi: 10.1089/cbr.2010.0899. Epub 2011 Jun 28.
Cancer Biother Radiopharm. 2011.
PMID: 21711100
Clinical Trial.